美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PagerDuty, Inc.

14.62

0.0000

盘后：14.620.00000.00%16:15 EDT

成交量：80.25万

成交额：1,178.03万

市值：13.48亿

市盈率：-36.30

高：14.85

开：14.76

低：14.60

收：14.62

数据加载中...

总览公司新闻公告

身价300亿，威海首富收获第四个IPO

医药生物：拥抱创新药大时代 PD-1双抗天价DEAL、ASCO摘要公布

中泰证券股份有...

港股异动 | 信达生物(01801)涨超4% PD-1/IL-2α双特异性抗体融合蛋白拟纳入突破性疗法

信达生物(01801)全球首创PD-1/IL-2α双特异性抗体融合蛋白拟纳入突破性疗法

招银国际：升三生制药(01530)目标价至28.32港元看好PD-1/VEGF双抗(SSGJ-707)潜力

美国大药企为何超百亿购中国一款药 PD-1/VEGF靶点受青睐

美国研究综述-Levi Strauss、Myriad Genetics、帕洛阿尔托

港股概念追踪|三生制药PD-1/VEGF双抗首个三期临床启动头对头挑战K药（附概念股）

【大行评级丨招商证券国际：上调三生制药目标价至25港元维持“买入”评级】招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。

康方生物早盘涨超7% 三生制药PD-1双抗出海刷新纪录

港股异动 | 康方生物(09926)涨超6% 三生制药PD-1双抗出海刷新纪录公司依沃西战胜K药

【创新药概念延续强势舒泰神20CM涨停】舒泰神20CM涨停，此前三生国健3连板，赛升药业、海创药业、海辰药业、诺思格、君实生物等跟涨。消息面上，港股创新药企三生制药公告称，其与辉瑞公司就前者自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议。本次协议中12.5亿美元的首付款再次刷新了国产创新药出海首付款金额纪录。

三生制药(01530)涨幅扩至36% 与辉瑞达成60.5亿美元PD-1/VEGF双抗全球授权

港股异动 | 三生制药(01530)暴涨40%逼近历史前高公司与辉瑞就PD-1/VEGF双抗达成授权协议

首付款12.5亿美元！三生制药与辉瑞达成PD-1抗体药物合作开发协议，创新药沪深港ETF大涨3%

每日经济新闻

辉瑞60.5亿押注三生制药，全球PD-1/VEGF双抗市场再掀波澜

华尔街见闻

港股异动 | 三生制药(01530)高开近15% 与辉瑞就PD-1/VEGF双抗达成授权协议涉资60.5亿美元

三生制药与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立许可协议

南方财经网

三生制药与辉瑞就PD-1/VEGF双抗SSGJ-707达成授权协议

【三生制药(01530.HK)与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立许可协议】三生制药(01530.HK)发布公告，于2025年5月19日，公司、沈阳三生制药有限责任公司(沈阳三生，公司的全资附属公司)及辉瑞公司(辉瑞)已订立独家许可协议。三生国健药业(上海)股份有限公司(三生国健，公司附属公司)亦将透过加入协议作为签署方加入。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/PD/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":14.62,"timestamp":1753128000000,"preClose":14.62,"halted":0,"volume":802546,"hourTrading":{"tag":"盘后","latestPrice":14.62,"preClose":14.62,"latestTime":"16:15 EDT","volume":45567,"amount":666189.5399999999,"timestamp":1753128917821},"delay":0,"floatShares":82117609,"shares":92173975,"eps":-0.402741,"marketStatus":"盘后交易","change":0,"latestTime":"07-21 19:20:32 EDT","open":14.76,"high":14.85,"low":14.6,"amount":11780304.438589,"amplitude":0.0171,"askPrice":14.99,"askSize":59,"bidPrice":14.05,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.402741,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753142400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":14.62,"preHourTrading":{"tag":"盘前","latestPrice":14.79,"preClose":14.62,"latestTime":"09:15 EDT","volume":59,"amount":867.91006,"timestamp":1753103719016},"postHourTrading":{"tag":"盘后","latestPrice":14.62,"preClose":14.62,"latestTime":"16:15 EDT","volume":45567,"amount":666189.5399999999,"timestamp":1753128917821},"volumeRatio":0.578892,"impliedVol":0.5338,"impliedVolPercentile":0.564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":82117609,"roa":"-3.27%","roe":"-19.13%","lyrEps":-0.591956,"volumeRatio":0.578892,"shares":92173975,"dividePrice":0,"high":14.85,"amplitude":0.0171,"preClose":14.62,"low":14.6,"week52Low":13.695,"pbRate":"9.25","psRate":"2.83","week52High":22.02,"institutionHeld":0,"latestPrice":14.62,"committee":-0.710145,"eps":-0.402741,"divideRate":0,"volume":802546,"delay":0,"ttmEps":-0.402741,"open":14.76,"prevYearClose":18.26,"prevWeekClose":14.62,"prevMonthClose":15.28,"prevQuarterClose":15.28,"fiveDayClose":14.96,"twentyDayClose":13.92,"sixtyDayClose":15.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538446584","title":"身价300亿，威海首富收获第四个IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2538446584","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538446584?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 14:35","pubTimestamp":1748414100,"startTime":"0","endTime":"0","summary":"虽然上市后持续股价持续下挫，但市值仍然接近150亿元。在2021年的“胡润百富榜”中，陈学利家族以150亿身价名列山东富豪榜第10名，是威海首富。而在由《山东商报》编制的“2024山东创富榜”中，陈学利家族的财富已经升至近330亿元，位列山东第5，威海第一。山外山的招股书显示，截止2022年山外山及其子公司具有已授权专利129项，其中境外专利2项，产品销往国内1000多家医院。在公开信息中，威高集团并没有做出回应，但并","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjzl/2025-05-28/doc-ineyayyz5981094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2756315664.SGD","LU0354030511.USD","HD","LU0943347566.SGD","159982","LU0820562030.AUD","LU1169589451.USD","LU0689472784.USD","LU1989772840.SGD","BK4588","LU1093756325.SGD","BK4023","BK4504","LU1989772923.USD","LU1674673428.USD","HP","BK4092","LU1914381329.SGD","LU1929549753.HKD","399300","BK4533","LU0823411888.USD","LU0868494617.USD","LU1551013342.USD","LU1778281490.HKD","IE00B1XK9C88.USD","BK4585","LU1496350171.SGD","BK4567","SG9999001440.SGD","LU0820561909.HKD","IE00BSNM7G36.USD","LU1069344957.HKD","LU1162221912.USD","LU1169590202.USD","BK4083","BK4550","LU1035775433.USD","BK4534","IE00BWXC8680.SGD","LU0234572021.USD","PD","BK4566","LU0868494708.USD","LU0942090050.USD","LU0823434583.USD","LU0820561818.USD","HF","LU0079474960.USD","LU0320765646.SGD"],"gpt_icon":0},{"id":"2538140135","title":"医药生物：拥抱创新药大时代 PD-1双抗天价DEAL、ASCO摘要公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2538140135","media":"中泰证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538140135?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 00:00","pubTimestamp":1748188800,"startTime":"0","endTime":"0","summary":"本周沪深300 下跌0.18%，医药生物上涨1.78%，处于31 个一级子行业第1 位。本周医药板块表现亮眼，得益于三生制药与辉瑞就PD-1/VEGF 双抗达成的12.5 亿美元首付款的BD 交易，刷新了国产创新药出海的首付款记录，催化了创新药高昂的投资热情，后续具备BD 预期的创新药个股均呈现出强劲上涨态势；此外本周四晚ASCO 研究摘要公布，国产创新药继续展现亮眼数据成果，进一步催化板块行情。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609450197655f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609450197655f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4592","LU1169589451.USD","LU1883839398.USD","LU0225284248.USD","LU1894683348.USD","SG9999011175.SGD","SGXZ57979304.SGD","PFE","LU1066051498.USD","IE00B19Z3581.USD","LU0306807586.USD","IE0002270589.USD","PD","LU1057294990.SGD","IE000M9KFDE8.USD","BK4585","LU0321505439.SGD","BK4588","LU0868494617.USD","IE00BLSP4239.USD","SG9999001176.SGD","LU0321505868.SGD","BK4534","LU0234572021.USD","BK4533","SG9999002224.SGD","LU1894683264.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","LU1169590202.USD","LU0225771236.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU0985481810.HKD","BK4023","BK4581","IE00B19Z3B42.SGD","LU0058720904.USD","LU0306806265.USD","LU0289739699.SGD","SG9999002232.USD","LU0170899867.USD","SG9999003800.SGD","LU0122379950.USD","SG9999001176.USD","BK4599","BK4550","LU1066053197.SGD","BK4007"],"gpt_icon":1},{"id":"2537077219","title":"港股异动 | 信达生物(01801)涨超4% PD-1/IL-2α双特异性抗体融合蛋白拟纳入突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2537077219","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537077219?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 15:22","pubTimestamp":1747984923,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，信达生物涨超4%，截至发稿，涨4.44%，报58.75港元，成交额25.26亿港元。本届 ASCO 年会将于当地时间2025年5月30日-6月3日在美国芝加哥举办。国家药品监督管理局药品审评中心官网显示，信达生物的PD-1/IL-2双特异性抗体融合蛋白IBI363拟纳入突破性疗法，用于治疗经含铂化疗及抗PD-1/PD-L1免疫治疗失败的局部晚期或转移性鳞状非小细胞肺癌。IBI363已获美国FDA两项快速通道资格认定，分别用于治疗晚期鳞状非小细胞肺癌和黑色素瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4023","BK1583","LU2328871848.SGD","LU1169590202.USD","LU2488822045.USD","BK1161","01801","LU1969619763.USD","BK1589","LU1169589451.USD","PD"],"gpt_icon":0},{"id":"2537902957","title":"信达生物(01801)全球首创PD-1/IL-2α双特异性抗体融合蛋白拟纳入突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2537902957","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537902957?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 14:55","pubTimestamp":1747983311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月23日，国家药品监督管理局药品审评中心官网显示，信达生物的PD-1/IL-2双特异性抗体融合蛋白IBI363拟纳入突破性疗法，用于治疗经含铂化疗及抗PD-1/PD-L1免疫治疗失败的局部晚期或转移性鳞状非小细胞肺癌。据悉，IBI363是由信达生物自主研发的全球首创PD-1/IL-2α-bias双特异性融合蛋白，同时具有阻断PD-1/PD-L1通路和激活IL-2通路两项功能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","LU1169590202.USD","LU1169589451.USD","BK1161","LU2328871848.SGD","LU2488822045.USD","BK4023","01801","LU1969619763.USD","PD","BK1589"],"gpt_icon":0},{"id":"2537985904","title":"招银国际：升三生制药(01530)目标价至28.32港元 看好PD-1/VEGF双抗(SSGJ-707)潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2537985904","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537985904?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 14:25","pubTimestamp":1747981506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，三生制药将PD-1/VEGF双抗的中国以外权益授予辉瑞 ，将获得12.5亿美元的首付款及最高达48亿美元的里程碑付款，并将获得双位数的产品销售分成，交易规模大幅超出市场预期。公司将保留707在中国的权益，而辉瑞将拥有707在中国商业化的选择权。此外，授权交易达成后，辉瑞还将以30日成交量加权平均价认购公司1亿美元的普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PD","01530"],"gpt_icon":0},{"id":"2537909830","title":"美国大药企为何超百亿购中国一款药 PD-1/VEGF靶点受青睐","url":"https://stock-news.laohu8.com/highlight/detail?id=2537909830","media":"新浪","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537909830?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 11:25","pubTimestamp":1747970745,"startTime":"0","endTime":"0","summary":"这款药物与康方生物的依沃西一样，靶点都是PD-1/VEGF。三生与辉瑞的这笔交易创下中国药物对外授权首付款最高纪录，但意外影响了康方生物。PD-1/VEGF是全球最具潜力的抗癌药靶点之一，多家跨国公司选择与中国创新药企合作开发，并支付高额首付款。这一次，三生系的涨势更猛，因为其首付款更高、合作伙伴更有说服力，且PD-1/VEGF的可行性和商业价值已由依沃西验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052313131994fffcb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052313131994fffcb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0306807586.USD","LU1894683348.USD","LU0985481810.HKD","BK4599","PD","LU0321505868.SGD","LU0122379950.USD","LU1169590202.USD","LU1066053197.SGD","01530","LU1023059063.AUD","LU0868494617.USD","IE00BBT3K403.USD","BK4592","BK4581","LU0225284248.USD","SG9999002232.USD","BK4534","IE0002270589.USD","IE000M9KFDE8.USD","SG9999001176.USD","LU1883839398.USD","LU0225771236.USD","LU1894683264.USD","LU0058720904.USD","LU0234572021.USD","LU0170899867.USD","BK4023","BK4550","BK4585","LU1169589451.USD","SG9999002224.SGD","IE00BLSP4239.USD","BK4568","IE00BLSP4452.SGD","SG9999013999.USD","SG9999003800.SGD","LU0289739699.SGD","BK4533","PFE","IE00B19Z3B42.SGD","LU0306806265.USD","BK4588","SG9999001176.SGD","SG9999011175.SGD","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066051498.USD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2537048566","title":"美国研究综述-Levi Strauss、Myriad Genetics、帕洛阿尔托","url":"https://stock-news.laohu8.com/highlight/detail?id=2537048566","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537048566?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 16:13","pubTimestamp":1747815213,"startTime":"0","endTime":"0","summary":"美国研究综述-Levi Strauss、Myriad Genetics、帕洛阿尔托路透5月21日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Levi Strauss、Myriad Genetics 和 Palo Alto Networks。要闻 * Levi Strauss & Co LEVI.N：巴克莱将其目标价从 18 美元上调至 20 美元  * Myriad Genetics Inc MYGN.O：丰业银行将目标价从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nL4T3RT0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4202","LU1548497426.USD","LU2357305700.SGD","LU0545562505.USD","LU1712237335.SGD","BK4581","IE00BFXG0V08.USD","LU2404859667.USD","LU2506951958.HKD","LU1228905037.USD","LU1721428933.USD","TTAN","LU2125909759.SGD","ADP","LU1989764748.USD","SG9999001424.SGD","LU1974910355.USD","LU2286300806.USD","LU2106854487.HKD","CSTL","BK4588","IE00BMPRXR70.SGD","LU0566484027.USD","LU0345774631.USD","BK4011","LU0690374961.EUR","LEVI","BK4106","EXP","LU1236620834.HKD","LU1861215975.USD","IE00B64QTZ34.USD","LU1236620750.USD","LU2023250843.SGD","MMSI","LU1691799644.USD","PD","OM","PANW","BK4516","IE00B5TLWC47.USD","LU1720051017.SGD","LU0965509101.SGD","BK4082","IE00B19Z8X17.USD","LU1934455194.USD","SDHC","MYGN","URI"],"gpt_icon":0},{"id":"2537608163","title":"港股概念追踪|三生制药PD-1/VEGF双抗首个三期临床启动    头对头挑战K药（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2537608163","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537608163?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 14:00","pubTimestamp":1747807234,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年5月20日，三生制药在ClinicalTrials.gov注册了PD-1/VEGF双抗SSGJ-707的一项三期临床试验，用于一线治疗PD-L1阳性晚期非小细胞肺癌，这是该品种迈入的首个III期临床研究。辉瑞引进三生制药PD-1/VEGF双抗SSGJ-707是三生制药自主研发的创新药物，目前正在中国进行多项临床研究，包括已获批的PD-L1阳性局部晚期或转移性非小细胞肺癌Ⅲ期临床试验，并已获得中国突破性疗法认定。三生制药与辉瑞达成60亿美元天价授权合作，创下中国创新药BD交易新纪录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0965509283.SGD","LU2106854487.HKD","LU1794554557.SGD","LU0266013472.USD","LU0238689110.USD","LU0965509101.SGD","09926","BK1574","LU1169590202.USD","LU1917777945.USD","LU2361045086.USD","LU0265550946.USD","LU1162221912.USD","LU0070302665.USD","LU2461242641.AUD","LU1585245621.USD","YANG","LU0320765489.SGD","LU1069347547.HKD","LU1169589451.USD","SG9999001176.SGD","LU1941712348.USD","LU1023059063.AUD","BK4534","LU2023250843.SGD","SG9999001176.USD","LU2361044865.SGD","PD","01530","LU1037948897.HKD","LU1116320737.USD","IE00BJT1NW94.SGD","LU1934455863.HKD","LU1037948541.HKD","LU0058720904.USD","IE00BLSP4452.SGD","BK4533","LU1066051498.USD","BK4588","LU2324357040.USD","LU2112291526.USD","LU0861579265.USD","LU1057294990.SGD","HSTECH","LU0965508806.USD","HSCEI","LU1941712264.USD","SG9999014559.SGD"],"gpt_icon":1},{"id":"2537267474","title":"【大行评级丨招商证券国际：上调三生制药目标价至25港元 维持“买入”评级】招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537267474","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537267474?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 12:13","pubTimestamp":1747800828,"startTime":"0","endTime":"0","summary":"招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21121350556709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06099","01530","PFE","01177","PD"],"gpt_icon":0},{"id":"2537671512","title":"康方生物早盘涨超7% 三生制药PD-1双抗出海刷新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2537671512","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537671512?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:18","pubTimestamp":1747797480,"startTime":"0","endTime":"0","summary":"　　康方生物股价上涨7.40%，现报88.50港元，成交额9.88亿港元。　　据每日经济新闻报道，三生制药PD-1双抗出海刷新纪录。青侨阳光基金经理林伟指出，从长期视角来看，PD-1双抗这一赛道市场广阔，容得下三到五家主流药企共同发展，“除了辉瑞，也还有很多其它药企有收购补全PD-1双抗的强烈意愿，也有众多的新兴ADC药企可以合作”。此外，辉瑞在与Summit短暂合作后就下决心重金引进潜在竞品，对PD1/VEGF双抗这一赛道本身也有背书效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-21/doc-inexhwwk8154063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B543WZ88.USD","LU0348784397.USD","BK1574","LU0348783233.USD","BK1161","09926","BK1593","LU2488822045.USD","BK1583","PD","01530","LU1169589451.USD","LU1169590202.USD","LU1720050803.USD","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK4023"],"gpt_icon":0},{"id":"2537867992","title":"港股异动 | 康方生物(09926)涨超6% 三生制药PD-1双抗出海刷新纪录 公司依沃西战胜K药","url":"https://stock-news.laohu8.com/highlight/detail?id=2537867992","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537867992?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:58","pubTimestamp":1747796333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康方生物涨超6%，截至发稿，涨6.49%，报87.75港元，成交额9.27亿港元。消息面上，据每日经济新闻报道，三生制药PD-1双抗出海刷新纪录。兴业证券指出，康方生物宣布全球首创双特异性抗体新药依沃西单抗对比K药在一线治疗PD-L1（TPS≥1%（NSCLC的国内III期临床取得显著阳性结果，为全球首个挑战K药成功的创新药，全球市场想象空间巨大。依沃西单抗以及卡度尼利单抗已顺利进入2024年医保目录，未来有望实现快速放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BLSP4239.USD","LU1037948541.HKD","LU1069347547.HKD","LU0965508806.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU1934455194.USD","BK1574","BK4588","SG9999014542.SGD","LU1983299246.USD","LU1571399168.USD","IE00B1BXHZ80.USD","LU2361044865.SGD","LU2324357040.USD","BK4023","IE00BSNM7G36.USD","BK4559","IE0002141913.USD","IE00BN8TJ469.HKD","SG9999014559.SGD","LU1116320901.HKD","IE0009355771.USD","LU1037948897.HKD","LU0106261372.USD","LU0006306889.USD","LU1585245621.USD","PD","LU0348783233.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1066051225.USD","LU0985320562.USD","LU0203347892.USD","LU1941712348.USD","SG9999002224.SGD","LU1929549753.HKD","LU0211331839.USD","09926","LU2023250504.SGD","LU0266013472.USD","LU1057294990.SGD","BK1583","LU1169590202.USD","IE00B543WZ88.USD","LU0122379950.USD","SG9999013999.USD","LU1061106388.HKD"],"gpt_icon":1},{"id":"2537161673","title":"【创新药概念延续强势 舒泰神20CM涨停】舒泰神20CM涨停，此前三生国健3连板，赛升药业、海创药业、海辰药业、诺思格、君实生物等跟涨。消息面上，港股创新药企三生制药公告称，其与辉瑞公司就前者自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议。本次协议中12.5亿美元的首付款再次刷新了国产创新药出海首付款金额纪录。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537161673","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537161673?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 09:44","pubTimestamp":1747791859,"startTime":"0","endTime":"0","summary":"舒泰神20CM涨停，此前三生国健3连板，赛升药业、海创药业、海辰药业、诺思格、君实生物等跟涨。消息面上，港股创新药企三生制药公告称，其与辉瑞公司就前者自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议。本次协议中12.5亿美元的首付款再次刷新了国产创新药出海首付款金额纪录。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21094450553896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4614","IE00B19Z3581.USD","SG9999013999.USD","BK4533","688180","01877","300584","159992","LU0985481810.HKD","LU0868494617.USD","300485","SG9999011175.SGD","BK4581","IE00BBT3K403.USD","SG9999002224.SGD","SGXZ57979304.SGD","LU1169590202.USD","YANG","BK0239","BK4534","HSTECH","SG9999001176.SGD","LU0058720904.USD","LU0234572021.USD","BK1574","LU1066051498.USD","IE0002270589.USD","300204","688302","LU0306806265.USD","688336","06978","PD","IE00BLSP4239.USD","LU0170899867.USD","LU0456855351.SGD","HSCEI","LU1894683264.USD","SG9999001176.USD","BK1583","BK0046","BK4599","BK0216","301333","LU1883839398.USD","BK1161","LU0122379950.USD"],"gpt_icon":0},{"id":"2536663263","title":"三生制药(01530)涨幅扩至36% 与辉瑞达成60.5亿美元PD-1/VEGF双抗全球授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2536663263","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536663263?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 11:09","pubTimestamp":1747710541,"startTime":"0","endTime":"0","summary":"金吾财讯 | 三生制药 涨幅扩大，截至发稿，涨36.41%，报19.78港元，成交额29.22亿港元。消息面上，公司与辉瑞就前者专有CLF2平台自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议 。辉瑞应负责承担许可产品在许可地区内的所有未来试验的开发及监管事务的所有费用。公司将向辉瑞配发及发行新股份的确切条款及数目将于正式协议中厘定及最终确定。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958954","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","BK4599","LU0225284248.USD","IE0002270589.USD","PFE","LU1894683264.USD","LU0234572021.USD","LU0306807586.USD","LU0321505439.SGD","LU1066053197.SGD","BK4550","BK1583","LU1066051498.USD","LU1883839398.USD","LU0306806265.USD","LU0122379950.USD","LU1057294990.SGD","SG9999003800.SGD","LU0170899867.USD","BK1161","LU0058720904.USD","BK4592","LU0225771236.USD","BK1593","BK4581","IE00B19Z3581.USD","BK4585","IE00BLSP4452.SGD","LU1169589451.USD","SG9999001176.USD","BK4534","LU0321505868.SGD","SG9999002232.USD","PD","IE00BBT3K403.USD","IE000M9KFDE8.USD","LU0868494617.USD","BK4533","SG9999011175.SGD","SG9999013999.USD","BK4007","IE00B19Z3B42.SGD","BK4023","LU0289739699.SGD","LU0456855351.SGD","IE00BLSP4239.USD","LU0985481810.HKD","BK4568","01530","BK4588"],"gpt_icon":1},{"id":"2536663807","title":"港股异动 | 三生制药(01530)暴涨40%逼近历史前高 公司与辉瑞就PD-1/VEGF双抗达成授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2536663807","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536663807?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 10:55","pubTimestamp":1747709757,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药早盘暴涨40%，盘中触及22港元，逼近历史前高22.63港元。消息面上，三生制药公告称，其与辉瑞公司就前者自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议 。同时，辉瑞将以30日成交量加权平均价，认购三生制药价值1亿美元的新发普通股 。据悉，SSGJ-707是三生制药旗下三生国健基于其专有CLF2平台自主研发的创新双抗药物。根据三生制药公告，SSGJ-707已在中国开展多项临床研究 。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0234572021.USD","LU1023059063.AUD","SG9999002224.SGD","LU0985481810.HKD","LU1066051498.USD","LU1057294990.SGD","LU1894683348.USD","SG9999011175.SGD","01530","LU0170899867.USD","PD","LU0868494617.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4592","LU0225771236.USD","BK4550","BK4581","IE00BLSP4452.SGD","BK4568","SG9999003800.SGD","BK4534","BK4585","SG9999002232.USD","BK1583","LU1066053197.SGD","BK4023","BK4533","IE00B19Z3581.USD","BK1593","IE00BBT3K403.USD","LU0321505439.SGD","LU0321505868.SGD","IE000M9KFDE8.USD","IE0002270589.USD","BK1161","LU0289739699.SGD","LU1894683264.USD","SGXZ57979304.SGD","LU1169590202.USD","LU0058720904.USD","SG9999013999.USD","BK4599","LU0225284248.USD","SG9999001176.SGD","BK4588","SG9999001176.USD","BK4007","LU0306806265.USD"],"gpt_icon":1},{"id":"2536668143","title":"首付款12.5亿美元！三生制药与辉瑞达成PD-1抗体药物合作开发协议，创新药沪深港ETF大涨3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536668143","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536668143?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 10:29","pubTimestamp":1747708152,"startTime":"0","endTime":"0","summary":"5月20日，三生制药公告称，其与辉瑞公司就前者自主研发的PD-1/VEGF双特异性抗体SSGJ-707签订了独家许可协议 。同时，辉瑞将以30日成交量加权平均价，认购三生制药价值1亿美元的新发普通股，这一里程碑式的交易刷新了近年来中国创新药对外授权的金额记录。全球领先的创新品种进入业绩放量兑现期，国际领先的临床突破或BD不断涌现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520103158a6e56dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520103158a6e56dcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4239.USD","LU1169589451.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4585","IE00BLSP4452.SGD","BK4588","LU0985481810.HKD","BK4534","LU0456855351.SGD","SG9999001176.SGD","BK4023","LU1066053197.SGD","LU1023059063.AUD","LU1894683348.USD","LU0321505439.SGD","LU1894683264.USD","SGXZ57979304.SGD","FDN","BK4533","BK4568","LU0225284248.USD","PD","BK4550","SG9999002232.USD","LU0306806265.USD","LU0868494617.USD","LU0234572021.USD","BK4581","BK4592","LU0058720904.USD","IE00B19Z3581.USD","SG9999011175.SGD","IE00BBT3K403.USD","PFE","BK4007","01530","LU0170899867.USD","IE0002270589.USD","LU0306807586.USD","SG9999003800.SGD","IE000M9KFDE8.USD","LU1057294990.SGD","LU1169590202.USD","BK4599","LU0289739699.SGD","LU0321505868.SGD","LU1066051498.USD","LU0122379950.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2536652918","title":"辉瑞60.5亿押注三生制药，全球PD-1/VEGF双抗市场再掀波澜","url":"https://stock-news.laohu8.com/highlight/detail?id=2536652918","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536652918?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 09:31","pubTimestamp":1747704677,"startTime":"0","endTime":"0","summary":"辉瑞抛弃Summit，转向三生。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3747423","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3747423","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","LU0170899867.USD","01530","LU1169589451.USD","PFE","IE00B19Z3581.USD","LU0985481810.HKD","BK1593","LU1066053197.SGD","BK4581","PD","LU0306807586.USD","SG9999013999.USD","LU1057294990.SGD","IE000M9KFDE8.USD","BK1161","LU0225284248.USD","SG9999002224.SGD","SG9999001176.SGD","BK4023","BK4599","LU1066051498.USD","LU0225771236.USD","LU1883839398.USD","LU1894683348.USD","BK4533","BK4534","LU0234572021.USD","LU1894683264.USD","IE0002270589.USD","LU0058720904.USD","BK4585","LU0289739699.SGD","SG9999011175.SGD","LU0868494617.USD","LU1023059063.AUD","BK4568","LU0321505439.SGD","SG9999002232.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0306806265.USD","LU0122379950.USD","BK4007","SG9999003800.SGD","LU0456855351.SGD","BK4592","SGXZ57979304.SGD","BK4550","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2536654020","title":"港股异动 | 三生制药(01530)高开近15% 与辉瑞就PD-1/VEGF双抗达成授权协议 涉资60.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536654020","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536654020?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 09:22","pubTimestamp":1747704136,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药高开近15%，截至发稿，涨14.9%，报16.66港元，成交额4067.54万港元。消息面上，5月20日，三生制药宣布，公司及附属子公司沈阳三生、三生国健与辉瑞签署协议，将向辉瑞独家授予公司自主研发的突破性PD-1/VEGF双特异性抗体SSGJ-707在全球的开发、生产、商业化权利。此外，辉瑞将于协议生效日认购三生制药价值1亿美元的普通股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","SG9999002224.SGD","LU0985481810.HKD","SG9999013999.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4007","BK4550","BK4581","BK4023","PD","LU0456855351.SGD","LU1169590202.USD","BK1593","IE00BLSP4452.SGD","LU0225771236.USD","LU1894683348.USD","SGXZ57979304.SGD","LU0306807586.USD","01530","LU0306806265.USD","IE0002270589.USD","BK4599","BK4534","SG9999002232.USD","BK1161","BK4588","BK4592","BK4533","LU1066051498.USD","LU0122379950.USD","LU0225284248.USD","LU0289739699.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999011175.SGD","LU1894683264.USD","LU0868494617.USD","IE00BLSP4239.USD","LU1023059063.AUD","SG9999003800.SGD","LU1066053197.SGD","IE000M9KFDE8.USD","LU1883839398.USD","LU0234572021.USD","LU0170899867.USD","IE00B19Z3581.USD","BK4585"],"gpt_icon":0},{"id":"2536659775","title":"三生制药与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2536659775","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536659775?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 08:17","pubTimestamp":1747700242,"startTime":"0","endTime":"0","summary":"南方财经5月20日电，三生制药公告，5月19日，公司、沈阳三生制药有限责任公司(沈阳三生，公司的全资附属公司)及辉瑞公司(辉瑞)已订立独家许可协议。三生国健药业(上海)股份有限公司(三生国健，公司附属公司)亦将透过加入协议作为签署方加入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505203408850655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","SGXZ57979304.SGD","SG9999002224.SGD","LU1894683348.USD","SG9999001176.USD","IE0002270589.USD","LU0306806265.USD","BK4599","LU0321505868.SGD","IE00BLSP4239.USD","LU1894683264.USD","BK4581","LU0170899867.USD","BK4534","01530","LU1066053197.SGD","SG9999013999.USD","LU1169590202.USD","BK1583","SG9999011175.SGD","IE00BBT3K403.USD","LU0225771236.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","BK4568","LU0225284248.USD","SG9999002232.USD","BK4007","LU0122379950.USD","LU1066051498.USD","LU0306807586.USD","LU0321505439.SGD","LU0985481810.HKD","BK4585","BK4592","LU0058720904.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK1161","LU0234572021.USD","LU0289739699.SGD","LU0868494617.USD","BK4023","BK4550","PD","LU1057294990.SGD","LU1169589451.USD","LU1023059063.AUD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2536656793","title":"三生制药与辉瑞就PD-1/VEGF双抗SSGJ-707达成授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2536656793","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536656793?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 08:04","pubTimestamp":1747699440,"startTime":"0","endTime":"0","summary":"5月20日，三生制药宣布，公司及附属子公司沈阳三生、三生国健与辉瑞签署协议，将向辉瑞独家授予公司自主研发的突破性PD-1/VEGF双特异性抗体SSGJ-707在全球的开发、生产、商业化权利。此外，辉瑞将于协议生效日认购三生制药价值1亿美元的普通股股份。SSGJ-707是三生制药基于CLF2专利平台开发的靶向PD-1/VEGF双特异性抗体，可同时抑制PD-1和VEGF双靶点。此前，SSGJ-707已获得FDA的IND批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052008040094fbfe19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052008040094fbfe19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","LU1894683348.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU0321505439.SGD","SG9999002232.USD","BK4007","IE00BLSP4239.USD","LU0289739699.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0306807586.USD","BK4592","LU1066053197.SGD","LU1066051498.USD","LU0122379950.USD","PD","BK4023","IE00BBT3K403.USD","LU0234572021.USD","LU1169589451.USD","LU1057294990.SGD","SG9999001176.SGD","LU0225284248.USD","LU0868494617.USD","BK4534","BK4588","BK4550","LU0170899867.USD","BK4533","LU1894683264.USD","SGXZ57979304.SGD","IE0002270589.USD","BK4585","LU0058720904.USD","LU1169590202.USD","01530","SG9999001176.USD","LU0321505868.SGD","LU0985481810.HKD","SG9999002224.SGD","SG9999003800.SGD","LU1023059063.AUD","IE00B19Z3581.USD","LU1883839398.USD","BK4599","SG9999011175.SGD","BK4581","BK4568","LU0456855351.SGD"],"gpt_icon":1},{"id":"2536465509","title":"【三生制药(01530.HK)与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立许可协议】三生制药(01530.HK)发布公告，于2025年5月19日，公司、沈阳三生制药有限责任公司(沈阳三生，公司的全资附属公司)及辉瑞公司(辉瑞)已订立独家许可协议。三生国健药业(上海)股份有限公司(三生国健，公司附属公司)亦将透过加入协议作为签署方加入。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536465509","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536465509?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 07:22","pubTimestamp":1747696931,"startTime":"0","endTime":"0","summary":"三生制药(01530.HK)发布公告，于2025年5月19日，公司、沈阳三生制药有限责任公司(沈阳三生，公司的全资附属公司)及辉瑞公司(辉瑞)已订立独家许可协议。三生国健药业(上海)股份有限公司(三生国健，公司附属公司)亦将透过加入协议作为签署方加入。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/20072250517653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SG9999001176.SGD","BK1161","LU1066053197.SGD","SG9999002232.USD","LU0234572021.USD","LU0225771236.USD","LU0170899867.USD","BK4534","LU0868494617.USD","BK4585","LU0321505868.SGD","SGXZ57979304.SGD","BK4592","LU1883839398.USD","688336","IE00BLSP4239.USD","LU0289739699.SGD","LU1894683348.USD","SG9999002224.SGD","BK0239","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU1169589451.USD","BK4533","LU0306806265.USD","IE000M9KFDE8.USD","01530","LU0122379950.USD","BK4581","BK4007","BK4023","LU1023059063.AUD","LU1057294990.SGD","PD","SG9999011175.SGD","LU0225284248.USD","LU0306807586.USD","IE00BLSP4452.SGD","LU1894683264.USD","SG9999003800.SGD","LU1169590202.USD","IE00B19Z3581.USD","BK4588","SG9999013999.USD","BK1593","BK1583","BK4599","IE0002270589.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":163,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-29","symbol":"PD","fiscalQuarterEnding":"2025/04","expectedEps":-0.06,"name":null,"time":"盘后","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-03-13","symbol":"PD","fiscalQuarterEnding":"2025/01","expectedEps":-0.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-11-26","symbol":"PD","fiscalQuarterEnding":"2024/10","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-09-03","symbol":"PD","fiscalQuarterEnding":"2024/07","expectedEps":-0.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-05-30","symbol":"PD","fiscalQuarterEnding":"2024/04","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0.3636,"hold":0.4545,"sell":0.0909,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4545,"analysts":11,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2025-07-18","current":-36.593825,"percent":0.290804,"low":-81.051795,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"high":-13.794086,"avg":-30.245097,"sd":13.265016,"marketCap":1350348733},"quantilePoints":[{"date":"2020-07-24","current":-42.807044,"twenty":-72.640646,"median":-42.989625,"eighty":-37.118318,"marketCap":2128965516},{"date":"2020-07-31","current":-48.235072,"twenty":-72.530247,"median":-43.175427,"eighty":-37.208604,"marketCap":2398923066},{"date":"2020-08-07","current":-47.238087,"twenty":-72.318638,"median":-43.360924,"eighty":-37.407321,"marketCap":2349339026},{"date":"2020-08-14","current":-46.177802,"twenty":-72.098738,"median":-43.468321,"eighty":-37.467623,"marketCap":2296606793},{"date":"2020-08-21","current":-45.95625,"twenty":-71.69039,"median":-43.550826,"eighty":-37.518859,"marketCap":2285588118},{"date":"2020-08-28","current":-48.583225,"twenty":-71.41486,"median":-43.699242,"eighty":-37.630539,"marketCap":2416238127},{"date":"2020-09-04","current":-38.528058,"twenty":-71.368789,"median":-43.748751,"eighty":-37.658486,"marketCap":1997756875},{"date":"2020-09-11","current":-36.766338,"twenty":-71.24954,"median":-43.637964,"eighty":-37.464273,"marketCap":1906408152},{"date":"2020-09-18","current":-38.03784,"twenty":-70.931543,"median":-43.525964,"eighty":-37.424178,"marketCap":1972338100},{"date":"2020-09-25","current":-40.596165,"twenty":-70.750862,"median":-43.369188,"eighty":-37.464273,"marketCap":2104992334},{"date":"2020-10-02","current":-42.378825,"twenty":-69.760733,"median":-43.304333,"eighty":-37.506887,"marketCap":2197426830},{"date":"2020-10-09","current":-45.308378,"twenty":-68.893466,"median":-43.360924,"eighty":-37.540906,"marketCap":2349330024},{"date":"2020-10-16","current":-46.719472,"twenty":-68.681421,"median":-43.459295,"eighty":-37.566006,"marketCap":2422498055},{"date":"2020-10-23","current":-44.664183,"twenty":-67.026675,"median":-43.550718,"eighty":-37.624584,"marketCap":2315927228},{"date":"2020-10-30","current":-41.565912,"twenty":-65.321463,"median":-43.550772,"eighty":-37.657731,"marketCap":2155275682},{"date":"2020-11-06","current":-46.121291,"twenty":-64.742086,"median":-43.550826,"eighty":-37.676934,"marketCap":2391481172},{"date":"2020-11-13","current":-46.35136,"twenty":-63.787431,"median":-43.643849,"eighty":-37.728931,"marketCap":2403410742},{"date":"2020-11-20","current":-47.79313,"twenty":-62.855819,"median":-43.781756,"eighty":-37.757248,"marketCap":2478169382},{"date":"2020-11-27","current":-52.440537,"twenty":-62.329113,"median":-43.973974,"eighty":-37.811067,"marketCap":2719146700},{"date":"2020-12-04","current":-58.503982,"twenty":-61.897872,"median":-44.116471,"eighty":-37.910083,"marketCap":3346135266},{"date":"2020-12-11","current":-61.956348,"twenty":-61.897872,"median":-44.23472,"eighty":-37.979009,"marketCap":3543593297},{"date":"2020-12-18","current":-64.76408,"twenty":-63.261641,"median":-44.342085,"eighty":-38.134161,"marketCap":3704181571},{"date":"2020-12-24","current":-65.981719,"twenty":-64.468982,"median":-44.366057,"eighty":-38.286785,"marketCap":3773824445},{"date":"2020-12-31","current":-59.735947,"twenty":-64.377301,"median":-44.622066,"eighty":-38.319351,"marketCap":3416597468},{"date":"2021-01-08","current":-63.775644,"twenty":-64.248374,"median":-44.664183,"eighty":-38.342002,"marketCap":3647647944},{"date":"2021-01-15","current":-65.265461,"twenty":-64.491902,"median":-44.85652,"eighty":-38.342002,"marketCap":3732858049},{"date":"2021-01-22","current":-70.007091,"twenty":-64.924465,"median":-44.940871,"eighty":-38.368803,"marketCap":4004055593},{"date":"2021-01-29","current":-69.806539,"twenty":-66.010369,"median":-45.124322,"eighty":-38.447577,"marketCap":3992585002},{"date":"2021-02-05","current":-78.774094,"twenty":-67.606194,"median":-45.279297,"eighty":-38.515566,"marketCap":4505484287},{"date":"2021-02-12","current":-81.051795,"twenty":-68.875403,"median":-45.308378,"eighty":-38.533013,"marketCap":4635757427},{"date":"2021-02-19","current":-74.533844,"twenty":-69.256452,"median":-45.492434,"eighty":-38.599807,"marketCap":4262963219},{"date":"2021-02-26","current":-64.090797,"twenty":-69.256452,"median":-45.616009,"eighty":-38.656949,"marketCap":3665673158},{"date":"2021-03-05","current":-53.862628,"twenty":-69.159583,"median":-45.671397,"eighty":-38.66724,"marketCap":3080673016},{"date":"2021-03-12","current":-60.509506,"twenty":-69.072496,"median":-45.726784,"eighty":-38.673459,"marketCap":3460841176},{"date":"2021-03-19","current":-49.639711,"twenty":-68.918379,"median":-45.797998,"eighty":-38.687063,"marketCap":3420324980},{"date":"2021-03-26","current":-46.372989,"twenty":-68.782324,"median":-45.852876,"eighty":-38.706425,"marketCap":3195238028},{"date":"2021-04-01","current":-49.627656,"twenty":-68.703922,"median":-45.852876,"eighty":-38.74149,"marketCap":3419494401},{"date":"2021-04-09","current":-50.688437,"twenty":-68.634603,"median":-45.95625,"eighty":-38.792193,"marketCap":3492585367},{"date":"2021-04-16","current":-50.965686,"twenty":-68.620415,"median":-46.098464,"eighty":-38.810779,"marketCap":3511688688},{"date":"2021-04-23","current":-50.965686,"twenty":-68.551655,"median":-46.177802,"eighty":-38.849388,"marketCap":3511688688},{"date":"2021-04-30","current":-51.182664,"twenty":-68.073194,"median":-46.296231,"eighty":-38.932876,"marketCap":3526639113},{"date":"2021-05-07","current":-45.52431,"twenty":-67.425697,"median":-46.35136,"eighty":-39.005886,"marketCap":3136761501},{"date":"2021-05-14","current":-42.286432,"twenty":-67.150653,"median":-46.187891,"eighty":-39.046881,"marketCap":2913662055},{"date":"2021-05-21","current":-44.081211,"twenty":-66.824039,"median":-46.121291,"eighty":-39.054259,"marketCap":3037327665},{"date":"2021-05-28","current":-49.295769,"twenty":-66.574781,"median":-46.172553,"eighty":-39.081958,"marketCap":3396626399},{"date":"2021-06-04","current":-36.968776,"twenty":-66.216652,"median":-46.172553,"eighty":-39.072116,"marketCap":2957576028},{"date":"2021-06-11","current":-42.279901,"twenty":-66.096321,"median":-46.075636,"eighty":-39.072116,"marketCap":3382476656},{"date":"2021-06-18","current":-45.709132,"twenty":-65.976077,"median":-45.923735,"eighty":-39.125091,"marketCap":3656821944},{"date":"2021-06-25","current":-47.162372,"twenty":-65.815901,"median":-46.067026,"eighty":-39.183405,"marketCap":3773084124},{"date":"2021-07-02","current":-44.130431,"twenty":-65.216755,"median":-46.011638,"eighty":-39.205083,"marketCap":3530522741},{"date":"2021-07-09","current":-45.834591,"twenty":-65.021933,"median":-45.883552,"eighty":-39.229781,"marketCap":3666858967},{"date":"2021-07-16","current":-40.199362,"twenty":-64.900098,"median":-45.829869,"eighty":-39.313533,"marketCap":3216029363},{"date":"2021-07-23","current":-43.325398,"twenty":-64.76408,"median":-45.766347,"eighty":-39.330284,"marketCap":3466118512},{"date":"2021-07-30","current":-42.436726,"twenty":-64.636745,"median":-45.712576,"eighty":-39.369202,"marketCap":3395022935},{"date":"2021-08-06","current":-44.33953,"twenty":-64.491902,"median":-45.685037,"eighty":-39.631794,"marketCap":3547251112},{"date":"2021-08-13","current":-42.269446,"twenty":-64.377301,"median":-45.655572,"eighty":-39.648544,"marketCap":3381640238},{"date":"2021-08-20","current":-40.387552,"twenty":-64.32,"median":-45.516041,"eighty":-39.732297,"marketCap":3231084897},{"date":"2021-08-27","current":-43.743597,"twenty":-64.248374,"median":-45.492434,"eighty":-39.784241,"marketCap":3499575255},{"date":"2021-09-03","current":-42.390054,"twenty":-64.090797,"median":-45.440934,"eighty":-39.784241,"marketCap":4025995391},{"date":"2021-09-10","current":-39.410762,"twenty":-63.838675,"median":-45.357157,"eighty":-39.773852,"marketCap":3743037083},{"date":"2021-09-17","current":-42.488469,"twenty":-63.43184,"median":-45.291593,"eighty":-39.773852,"marketCap":4035342362},{"date":"2021-09-24","current":-41.531159,"twenty":-63.322968,"median":-45.131991,"eighty":-39.806871,"marketCap":3944421825},{"date":"2021-10-01","current":-37.845067,"twenty":-63.294318,"median":-44.969953,"eighty":-39.673042,"marketCap":3594335269},{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733}],"updateTime":1753104840901}}}